Event Group
Event Groups are part of the Adverse Events Module within the Results Section. They provide a way to organize and summarize adverse event data by grouping related events together.
Each Event Group typically represents a category or class of adverse events and includes statistical information such as the number of participants affected and at risk for different event types: deaths, serious events, and other events.
Event Group path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Group
Event Group
Ignite Creation Date:
2025-12-24 @ 11:48 AM
Ignite Modification Date:
2025-12-26 @ 10:20 AM
NCT ID:
NCT05528861
Group ID:
EG003
Title:
Placebo Rollover (OLE)
Description:
Subjects in this arm received placebo in the main study and rolled over to receive up to 6 doses of 300 mg AK002 SC in the open-label extension (OLE) period.
Placebo: Placebo
AK002: Lirentelimab (AK002) is a humanized non-fucosylated immunoglobulin G1 (IgG1) monoclonal antibody directed against Siglec-8
Deaths Number Affected:
0
Deaths Number At Risk:
None
Serious Number Affected:
2
Serious Number At Risk:
57
Other Number Affected:
19
Other Number At Risk:
57
Study:
NCT05528861
Results Section:
NCT05528861
Adverse Events Module:
NCT05528861